Oncotarget · 2015 · 47 citations · 24 references
MedicineMolecular BiologyOncologyChemotherapyDna RepairMolecular OncologyChromatinColorectal CancerDna Double-strand Break RepairDna Strand BreaksDouble-strand Break RepairHomologous RecombinationDna Damage InductionDna Damage Repair PathwaysDouble-strand Break Repair PathwaysDouble-strand Dna BreaksGamma-h2ax SignalingHomologous Recombination RepairNeoadjuvant Chemoradiationγ-H2ax Foci Formation
// Upadhyayula Sai Srinivas 1 , Jerzy Dyczkowski 2 , Tim Beißbarth 2 , Jochen Gaedcke 3 , Wael Y. Mansour 4,5 , Kerstin Borgmann 4 and Matthias Dobbelstein 1 1 Institute of Molecular Oncology, University Medical Center Göttingen, Germany 2 Department of Medical Stastics, University Medical Center Göttingen, Germany 3 Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Germany 4 Laboratory of Radiobiology & Experimental Radiooncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany 5 Tumor Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt Correspondence to: Matthias Dobbelstein, email: // Keywords : colorectal cancer, radiochemotherapy, homologous recombination repair, 5-fluorouracil, Rad51 Received : November 19, 2014 Accepted : March 11, 2015 Published : March 30, 2015 Abstract Malignant tumors of the rectum are treated by neoadjuvant radiochemotherapy. This involves a combination of 5-fluorouracil (5-FU) and double stranded DNA-break (DSB)-inducing radiotherapy. Here we explored how 5-FU cooperates with DSB-induction to achieve sustainable DNA damage in colorectal cancer (CRC) cells. After DSB induction by neocarzinostatin, phosphorylated histone 2AX (γ-H2AX) rapidly accumulated but then largely vanished within a few hours. In contrast, when CRC cells were pre-treated with 5-FU, gammaH2AX remained for at least 24 hours. GFP-reporter assays revealed that 5-FU decreases the efficiency of homologous recombination (HR) repair. However, 5-FU did not prevent the initial steps of HR repair, such as the accumulation of RPA and Rad51 at nuclear foci. Thus, we propose that 5-FU interferes with the continuation of HR repair, e. g. the synthesis of new DNA strands. Two key mediators of HR, Rad51 and BRCA2, were found upregulated in CRC biopsies as compared to normal mucosa. Inhibition of HR by targeting Rad51 enhanced DNA damage upon DSB-inducing treatment, outlining an alternative way of enhancing therapeutic efficacy. Taken together, our results strongly suggest that interfering with HR represents a key mechanism to enhance the efficacy when treating CRC with DNA-damaging therapy.
24
DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139
Emmy P. Rogakou, Duane R. Pilch, Ann H. Orr et al. · Journal of Biological Chemistry · 1998 · 5.4K citations · Full text
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Jiřina Bártková, Zuzana Hořejšı́, Karen Koed et al. · Nature · 2005 · 2.7K citations
Medicine, Cancer Biology, Oncology +16
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Raffaella Di Micco, Marzia Fumagalli, Angelo Cicalese et al. · Nature · 2006 · 1.8K citations